GLPwatch
Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits.
Diabetes Care · 2010
Last updated 2026-05-28| Journal | Diabetes Care, 2010 |
|---|---|
| Citations | 241 |
| Relative citation ratio | 7.18 |
| NIH percentile | 96 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Full record and abstract on PubMed 20103558 ↗